Liminal BioSciences Liminal BioSciences is a biotechnology company developing small molecule compounds for respiratory, liver, and renal diseases. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | |
Founding Date | Founding Date 1994 | Founding Date 1978 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Laval, CA HQ Pampisford, GB | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations HQ |
Employees | Employees 251 | Employees 7,605 | Employees 4,595 |
Financial | |||
Revenue (est.) | Revenue (est.) $416k (FY, 2022) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) ¥3.7b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods ¥533.6m (FY, 2024) |
Gross profit | Gross profit $416k (FY, 2022) | Gross profit $7.5b (FY, 2025) | Gross profit ¥3.2b (FY, 2024) |
Net income | Net income $1.2m (FY, 2022) | Net income $1.3b (FY, 2025) | Net income ¥482.7m (FY, 2024) |
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyYiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View company